Utility of CCR7 to differentiate classic Hodgkin lymphoma and other B-cell lymphomas by flow cytometry and immunohistochemistry.

Xueyan ChenLori SomaClaire MurphyMaria TretiakovaKikkeri N NareshJonathan R Fromm

Published in: American journal of clinical pathology (2024)

The expression of CCR7 in HRS cells suggests its potential utility in differentiating CHL from other B-cell lymphomas. Incorporating CCR7 into flow cytometry and IHC panels may further enhance the diagnostic sensitivity of CHL.

Keyphrases

flow cytometry
hodgkin lymphoma
dendritic cells
regulatory t cells
induced apoptosis
poor prognosis
cell cycle arrest
magnetic resonance imaging
binding protein
endoplasmic reticulum stress
oxidative stress
magnetic resonance